A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation
Clinical trial NCT02042378 · COMPLETED
Trial details
- NCT number
- NCT02042378
- Sponsor
- pharmaand GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2016-04-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.